Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome Surges As Its Newest Product Shines. But BioXcel Does The Opposite.
09:25am, Monday, 08'th May 2023
Shares of Axsome Therapeutics and BioXcel Therapeutics diverged Monday after the duo reported first-quarter sales of their newest products. The post Axsome Surges As Its Newest Product Shines.
Axsome Therapeutics: Things Are Coming Together Nicely
02:08pm, Tuesday, 02'nd May 2023
Axsome Therapeutics, Inc. has a lot of good things happening. Axsome Therapeutics has the potential to become a large CNS-focused biopharma.
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
06:26am, Friday, 28'th Apr 2023
The biotech sector is up 4.76% so far in 2023. This continues the nice run that biotech stocks had in 2022.
Axsome Therapeutics Stock: Bear vs. Bull
05:30am, Sunday, 23'rd Apr 2023
Axsome recently launched two potential blockbusters. At the same time, expenses are rising, and the company's net loss is widening.
3 Stocks With Huge Catalysts on the Way
06:18am, Saturday, 22'nd Apr 2023
Axsome Therapeutics has several major milestones around the corner. CRISPR Therapeutics could soon win approvals for its first product.
Axsome (AXSM) Focuses on Auvelity Launch to Fuel Its Growth
01:43pm, Friday, 21'st Apr 2023
Axsome's (AXSM) earnings benefit from the launch of Auvelity (AXS-05), meant for treating major depressive disorders.
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of Neurology (AAN) Annual Meeting
07:00am, Friday, 21'st Apr 2023
NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous syste
The Top 3 Biotech Stocks to Watch in 2023
10:07am, Thursday, 20'th Apr 2023
Investors may want to keep an eye on the biotech boom and these top biotech stocks to watch. For one, the sector is still one of the safest, most recession-proof investments around.
2 Beaten-Down Growth Stocks to Buy in April
09:45am, Thursday, 20'th Apr 2023
Axsome is expecting important developments that should improve its already-bright prospects. Tandem's innovative insulin pump should allow it to capture a larger share of the diabetes market.
1 Risky Growth Stock Wall Street Says Is Poised for a 47% Rally
06:20am, Thursday, 20'th Apr 2023
Axsome just launched two treatments, Sunosi and Auvelity, and it could launch two others soon. It will take a while for sales to ramp up, and for the company to turn a profit.
Could Axsome Therapeutics Stock Help You Become a Millionaire?
08:30am, Sunday, 16'th Apr 2023
Axsome Therapeutics stock has generated significant gains over the past year. Analysts still see much more upside thanks to the biotech's growth potential.
Better Growth Stock: Axsome vs. CRISPR Therapeutics
05:30am, Sunday, 16'th Apr 2023
Axsome last year launched two products that could bring in revenue of more than $1 billion each. CRISPR Therapeutics recently completed regulatory requests for its first potential product.
Is It Too Late to Buy Axsome Therapeutics Stock?
10:15am, Saturday, 15'th Apr 2023
Axsome's stock trounced the market over the last 12 months. The biotech is ramping up sales of two recently approved therapies.
Axsome Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
07:00am, Friday, 14'th Apr 2023
NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous syste
Axsome Therapeutics to Report First Quarter 2023 Financial Results on May 8
07:00am, Thursday, 13'th Apr 2023
Axsome to host conference call and webcast on Monday, May 8, 2023, at 8:00 a.m. Eastern Time Axsome to host conference call and webcast on Monday, May 8, 2023, at 8:00 a.m. Eastern Time
